10.1371/journal.ppat.1003846 32 ChatterjeeM.HuangL
iii) cardiovascular pathologies such as heart failure, congenital diseases and cardiovascular malformations, as well as pathologies with genetic determinism (Brugada syndrome, long QT, arrhythmogenic dysplasia of the right ventricle), chronic ischemic heart disease, hypertension, myocarditis, pericarditis, vascular disease, electric pacemaker devices
3 Of the two dominant incretins, GIP has been shown to have a greater effect on insulin release following oral glucose ingestion in healthy humans
CagriSema injection is a long-acting combination therapy under development by Novo Nordisk, the main components are GLP-1 (glucagon-like peptide-1) receptor agonist smeglutide and a long-acting amylin analog cagrilintide
C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus